Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
万氏阳和解凝膏 is a traditional Chinese medicine (TCM) topical plaster specifically formulated for the treatment of breast hyperplasia (mammary gland hyperplasia). It is a specialized variation of the classic Yang He Jie Ning Gao formulation, designed to warm yang, resolve dampness, reduce swelling, and disperse nodules. The preparation contains a complex mixture of herbal ingredients, including *Arctium lappa* (牛蒡草), *Impatiens balsamina* (凤仙透骨草), *Aconitum* species (川乌, 草乌, 附子), and *Cinnamomum cassia* (肉桂, 桂枝). Clinical research, including a 2021 study, has indicated that the external application of this plaster is effective in relieving breast pain and reducing the size of breast lumps associated with hyperplastic conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 万氏阳和解凝膏.